{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:34:49Z","timestamp":1777617289772,"version":"3.51.4"},"reference-count":14,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016304","name":"Medtronic plc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,30]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"\n Introduction<\/jats:title>\n Ventral hernia repair is among the most commonly performed general surgical procedures, during which meshes are often used to provide further support to weakened or damaged tissue surrounding the hernia repair site. Slowly resorbable synthetic meshes have recently emerged as a valid choice, as confirmed by published clinical evidence on launched meshes in the repair of ventral hernias showing satisfactory results. This study was designed to assess the performance and safety of a newly developed slowly fully resorbable self-gripping synthetic mesh in patients undergoing ventral hernia repair through open surgery in clean and clean-contaminated fields.<\/jats:p>\n <\/jats:sec>\n \n Methods and analysis<\/jats:title>\n This is a prospective, multicentre, single-arm study that will be conducted in up to 20 European and US sites with a total of 163 patients undergoing midline primary or incisional ventral hernia repair in clean or clean-contaminated surgical fields using an open surgical approach and implanted with Transorb self-gripping resorbable mesh in retrorectus placement with or without transversus abdominis release. The study will include patients \u226518 years old, presenting at least one risk factor impairing wound healing. The primary endpoint will be hernia recurrence rate within 12 months, postoperatively evaluated by physical exam; secondary endpoints will include hernia recurrence rate within 1 month, 6 months, 24 months, 36 months, 48 months and 60 months postoperatively, hernia recurrence rate resulting in reoperation, hernia recurrence rate reported by patients, time to hernia recurrence, rate of surgical site occurrence (SSO), rate of SSO requiring procedural interventions, surgeon satisfaction and change in patient-reported pain and quality of life. The study will be considered successful if the upper limit of the 95% Bayesian credible interval for the primary endpoint is less than 14.2%. Descriptive statistics will be used to summarise secondary study endpoints unless otherwise noted.<\/jats:p>\n <\/jats:sec>\n \n Ethics and dissemination<\/jats:title>\n The multicentre, single-arm, prospective study of Transorb self-gripping resorbable mesh in subjects undergoing open repair of ventral hernia study will be conducted in compliance with the Good Clinical Practice standards, ISO 14155:2020 and the Declaration of Helsinki. The publication plan includes dissemination of the 12-month, 24-month, 36-month, 48-month and 60\u2009month study results.<\/jats:p>\n <\/jats:sec>\n \n Trial registration number<\/jats:title>\n \n The RECOVER study has been registered at clinicaltrials.gov (\n NCT06449378<\/jats:ext-link>\n ).\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-100294","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T10:05:30Z","timestamp":1752746730000},"page":"e100294","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["New synthetic resorbable mesh for open ventral hernia repair: the multicentre, single-arm, prospective study of Transorb self-gripping resorbable mesh in subjects undergoing open repair of ventral hernia in clean and clean-contaminated fields (RECOVER) protocol"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct06449378","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06449378","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06449378","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-6162","authenticated-orcid":false,"given":"J. Scott Scott","family":"Roth","sequence":"first","affiliation":[{"name":"Surgery, University of Kentucky College of Medicine, Lexington, Kentucky, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Ramshaw","sequence":"additional","affiliation":[{"name":"Caresyntax Corp, Knoxville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohann","family":"Renard","sequence":"additional","affiliation":[{"name":"Reims University Hospital, Reims, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-3491","authenticated-orcid":false,"given":"G","family":"Passot","sequence":"additional","affiliation":[{"name":"Surgical Oncology, Lyon 1 University, Oullins, Lyon, France, Lyon, France"},{"name":"Centre Hospitalier Universitaire de Lyon, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Berrevoet","sequence":"additional","affiliation":[{"name":"Department of General and HPB Surgery and Liver Transplantation, University Hospital Ghent, Gent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Bayliss","sequence":"additional","affiliation":[{"name":"Medtronic Inc, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4233-8933","authenticated-orcid":false,"given":"Marion","family":"Blanc","sequence":"additional","affiliation":[{"name":"Medtronic, Treveaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Cain","sequence":"additional","affiliation":[{"name":"Medtronic Inc, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7260-9630","authenticated-orcid":false,"given":"Matthew","family":"Goldblatt","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee, Wisconsin, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"2025121219265089000_15.7.e100294.1","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1055\/s-0042-1749428","article-title":"An Evaluation of the Evidence Guiding Adult Midline Ventral Hernia Repair","volume":"8","author":"Sagar","year":"2022","journal-title":"Surg J (N Y)"},{"key":"2025121219265089000_15.7.e100294.2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10029-012-0912-7","article-title":"EuraHS: the development of an international online platform for registration and outcome measurement of ventral abdominal wall hernia repair","volume":"16","author":"Muysoms","year":"2012","journal-title":"Hernia"},{"key":"2025121219265089000_15.7.e100294.3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/01.sla.0000141193.08524.e7","article-title":"Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia","volume":"240","author":"Burger","year":"2004","journal-title":"Ann Surg"},{"key":"2025121219265089000_15.7.e100294.4","doi-asserted-by":"crossref","DOI":"10.3390\/membranes7030047","article-title":"Past, Present and Future of Surgical Meshes: A Review","volume":"7","author":"Bayl\u00f3n","year":"2017","journal-title":"Membranes (Basel)"},{"key":"2025121219265089000_15.7.e100294.5","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1007\/s00464-023-10082-1","article-title":"Comparative long-term effectiveness between ventral hernia repairs with biosynthetic and synthetic mesh","volume":"37","author":"Morrison","year":"2023","journal-title":"Surg Endosc"},{"key":"2025121219265089000_15.7.e100294.6","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000366","article-title":"Five-Year Follow-Up of a Slowly Resorbable Biosynthetic P4HB Mesh (Phasix) in VHWG Grade 3 Incisional Hernia Repair","volume":"4","author":"Van den Dop","year":"2023","journal-title":"Ann Surg Open"},{"key":"2025121219265089000_15.7.e100294.7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/SLA.0000000000001601","article-title":"Multicenter, Prospective, Longitudinal Study of the Recurrence, Surgical Site Infection, and Quality of Life After Contaminated Ventral Hernia Repair Using Biosynthetic Absorbable Mesh: The COBRA Study","volume":"265","author":"Rosen","year":"2017","journal-title":"Ann Surg"},{"key":"2025121219265089000_15.7.e100294.8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jamcollsurg.2019.12.008","article-title":"Safety and Efficacy of Synthetic Mesh for Ventral Hernia Repair in a Contaminated Field","volume":"230","author":"Warren","year":"2020","journal-title":"J Am Coll Surg"},{"key":"2025121219265089000_15.7.e100294.9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s13304-022-01433-z","article-title":"Absorbable mesh in a contaminated field: hernia repair outcomes","volume":"75","author":"Wagner","year":"2023","journal-title":"Updates Surg"},{"key":"2025121219265089000_15.7.e100294.10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/bjs\/znac302","article-title":"Updated guideline for closure of abdominal wall incisions from the European and American Hernia Societies","volume":"109","author":"Deerenberg","year":"2022","journal-title":"Br J Surg"},{"key":"2025121219265089000_15.7.e100294.11","doi-asserted-by":"crossref","DOI":"10.1007\/s10856-023-06762-y","article-title":"A novel self-gripping long-term resorbable mesh providing temporary support for open primary ventral and incisional hernia","volume":"34","author":"Vestberg","year":"2023","journal-title":"J Mater Sci Mater Med"},{"key":"2025121219265089000_15.7.e100294.12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/10543406.2014.888569","article-title":"Not too big, not too small: a goldilocks approach to sample size selection","volume":"24","author":"Broglio","year":"2014","journal-title":"J Biopharm Stat"},{"key":"2025121219265089000_15.7.e100294.13","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znad284"},{"key":"2025121219265089000_15.7.e100294.14","unstructured":"US fda guidance on design considerations for pivotal clinical investigations for medical devices. 2013."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-100294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:27:00Z","timestamp":1765596420000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-100294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":14,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,17]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjopen-2025-100294"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-100294","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}